Trial Profile
Safety, Pharmacokinetics and Pharmacodynamics After Multiple Oral Doses of BIBR 1048 MS Capsule (150 mg b.i.d., 7 Days) in Healthy Japanese Male Subjects (Open Label Study)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jun 2014
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Deep vein thrombosis; Embolism; Pulmonary embolism; Stroke; Venous thromboembolism
- Focus Adverse reactions
- 26 Jun 2014 New trial record